The market for implantable medical devices will increase by 9.3% annually to reach $43.6 billion in 2011 and $67.3 billion by 2016, market researchers at the Freedonia Group suggest in a new report. Sales of drug-eluting coronary stents, despite recent setbacks, will grow by 11% annually, the Cleveland-based company estimates, and reach almost $7 billion and $11 billion by 2011 and 2016 respectively.
